XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Research and development expenses, net $ 1,100 $ 901
General and administrative expenses 4,167 8,734
Operating loss (5,267) (9,635)
Financing expenses, net 2,322 28
Net loss $ (7,589) $ (9,663)
Net loss per share, basic and diluted $ 0.18 $ 0.4
Weighted-average number of common shares outstanding, basic and diluted 32,682,401 14,293,737